As the U.S. organ waitlist continues its advance past 90,000, the aging population, diabetes and hypertension will increase organ failures into the future. Tissue remains in critically short supply as well. The recent discoveries and gains of the HHS Organ Breakthrough Collaborative must be sustained and expanded in order to bring the crisis under control.

To maximize these efforts, Transplant Connect introduces the Transplant Enterprise^SM Platform system - breakthrough technology that resolves the core information and communications challenges faced by OPOs, hospitals, transplant centers, tissue banks and other participants.

To learn more, contact us directly at 310 392 1400 or at contact@transplantconnect.com